WallStSmart

NexGen Energy Ltd. (NXE)vsUranium Royalty Corp (UROY)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

UROY leads profitability with a 8.0% profit margin vs 0.0%. UROY earns a higher WallStSmart Score of 52/100 (C-).

NXE

Avoid

23

out of 100

Grade: F

Growth: 4.3Profit: 3.0Value: 5.0Quality: 4.0
Piotroski: 1/9Altman Z: 0.99

UROY

Buy

52

out of 100

Grade: C-

Growth: 6.0Profit: 5.5Value: 3.0Quality: 8.5
Piotroski: 2/9Altman Z: 151.37
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for NXE.

UROYSignificantly Overvalued (-189.3%)

Margin of Safety

-189.3%

Fair Value

$1.40

Current Price

$3.46

$2.06 premium

UndervaluedFair: $1.40Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NXE0 strengths · Avg: 0/10

No standout strengths identified

UROY4 strengths · Avg: 9.5/10
Revenue GrowthGrowth
4164.0%10/10

Revenue surging 4164.0% year-over-year

Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
151.3710/10

Safe zone — low bankruptcy risk

Price/BookValuation
1.8x8/10

Reasonable price relative to book value

Areas to Watch

NXE4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Operating MarginProfitability
0.0%3/10

Operating margin of 0.0%

UROY4 concerns · Avg: 3.3/10
EPS GrowthGrowth
4.6%4/10

4.6% earnings growth

Market CapQuality
$499.49M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
1.3%3/10

ROE of 1.3% — below average capital efficiency

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : NXE

NXE has a balanced fundamental profile.

Bull Case : UROY

The strongest argument for UROY centers on Revenue Growth, Debt/Equity, Altman Z-Score. Revenue growth of 4164.0% demonstrates continued momentum.

Bear Case : NXE

The primary concerns for NXE are Revenue Growth, EPS Growth, Profit Margin.

Bear Case : UROY

The primary concerns for UROY are EPS Growth, Market Cap, Return on Equity. A P/E of 113.7x leaves little room for execution misses.

Key Dynamics to Monitor

NXE profiles as a value stock while UROY is a hypergrowth play — different risk/reward profiles.

UROY carries more volatility with a beta of 1.69 — expect wider price swings.

UROY is growing revenue faster at 4164.0% — sustainability is the question.

UROY generates stronger free cash flow (9M), providing more financial flexibility.

Bottom Line

UROY scores higher overall (52/100 vs 23/100) and 4164.0% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

NexGen Energy Ltd.

ENERGY · URANIUM · USA

NexGen Energy Ltd., an exploration and development company, is engaged in the acquisition, exploration and evaluation and development of uranium properties in Canada. The company is headquartered in Vancouver, Canada.

Uranium Royalty Corp

ENERGY · URANIUM · USA

Uranium Royalty Corp. The company is headquartered in Vancouver, Canada.

Visit Website →

Want to dig deeper into these stocks?